| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
|
13,474 |
12,538 |
$2.83M |
| 99284 |
|
8,338 |
7,769 |
$1.61M |
| 99282 |
|
3,205 |
3,046 |
$693K |
| 99285 |
|
3,439 |
3,187 |
$648K |
| 36415 |
|
26,783 |
11,186 |
$547K |
| 96365 |
|
1,998 |
1,407 |
$490K |
| 80053 |
|
12,548 |
10,830 |
$465K |
| 97530 |
|
4,753 |
1,304 |
$390K |
| 70450 |
|
1,345 |
1,281 |
$380K |
| 96361 |
|
1,246 |
1,111 |
$307K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,140 |
3,923 |
$300K |
| 74177 |
|
1,048 |
1,003 |
$293K |
| 81025 |
|
2,811 |
2,693 |
$203K |
| 43239 |
|
170 |
170 |
$169K |
| 80307 |
|
1,847 |
1,649 |
$146K |
| 74176 |
|
421 |
404 |
$129K |
| 96372 |
|
2,410 |
2,030 |
$117K |
| 87635 |
|
2,841 |
2,660 |
$77K |
| 80048 |
|
1,425 |
1,332 |
$60K |
| 97110 |
|
890 |
229 |
$56K |
| 97010 |
|
2,787 |
795 |
$54K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,275 |
2,187 |
$51K |
| 88342 |
|
252 |
252 |
$50K |
| 96360 |
|
186 |
184 |
$43K |
| 96374 |
|
3,204 |
2,941 |
$40K |
| 88305 |
|
414 |
389 |
$33K |
| 83880 |
|
769 |
721 |
$27K |
| 97140 |
|
585 |
150 |
$24K |
| 96375 |
|
2,326 |
2,024 |
$24K |
| 71045 |
|
1,820 |
1,680 |
$22K |
| 93005 |
|
2,942 |
2,641 |
$21K |
| 99281 |
|
113 |
112 |
$20K |
| 85025 |
|
9,069 |
7,763 |
$18K |
| 71046 |
|
970 |
942 |
$14K |
| 97161 |
|
113 |
112 |
$12K |
| 71275 |
|
41 |
39 |
$11K |
| OP250 |
|
811 |
445 |
$7K |
| 76700 |
|
42 |
42 |
$6K |
| 87804 |
|
2,488 |
1,402 |
$5K |
| 77067 |
|
83 |
83 |
$5K |
| 76856 |
|
12 |
12 |
$5K |
| 86900 |
|
138 |
130 |
$5K |
| 84484 |
|
1,959 |
1,562 |
$4K |
| 84703 |
|
587 |
553 |
$4K |
| 86901 |
|
140 |
131 |
$4K |
| 86850 |
|
109 |
103 |
$3K |
| 87880 |
|
903 |
862 |
$3K |
| 83735 |
|
1,821 |
1,410 |
$3K |
| 81001 |
|
2,765 |
2,575 |
$3K |
| 84443 |
|
364 |
360 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
100 |
95 |
$3K |
| 80076 |
|
138 |
133 |
$3K |
| 0012A |
|
84 |
84 |
$3K |
| 96366 |
|
14 |
12 |
$2K |
| 87086 |
|
392 |
378 |
$2K |
| 90715 |
|
108 |
106 |
$2K |
| 87081 |
|
631 |
606 |
$2K |
| 0011A |
|
74 |
74 |
$2K |
| 77063 |
|
25 |
25 |
$2K |
| 83690 |
|
1,568 |
1,432 |
$2K |
| 85610 |
|
1,885 |
1,750 |
$2K |
| 85730 |
|
1,495 |
1,410 |
$1K |
| 80061 |
|
213 |
212 |
$1K |
| 81003 |
|
1,786 |
1,659 |
$1K |
| 72125 |
|
12 |
12 |
$1K |
| 94640 |
|
294 |
274 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
246 |
235 |
$743.07 |
| 82077 |
|
778 |
666 |
$649.35 |
| 0001A |
|
16 |
16 |
$640.00 |
| 0002A |
|
15 |
15 |
$600.00 |
| 0031A |
|
15 |
15 |
$551.64 |
| 80306 |
|
230 |
206 |
$425.16 |
| 82306 |
|
12 |
12 |
$402.05 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,554 |
1,292 |
$377.74 |
| 82803 |
|
12 |
12 |
$372.79 |
| 73630 |
|
43 |
40 |
$330.30 |
| 73130 |
|
17 |
14 |
$223.23 |
| 83605 |
|
146 |
135 |
$220.06 |
| 73610 |
|
37 |
37 |
$216.32 |
| 85027 |
|
69 |
64 |
$182.81 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
174 |
154 |
$168.33 |
| 85379 |
|
233 |
219 |
$159.49 |
| 93010 |
|
20 |
13 |
$157.50 |
| 87070 |
|
143 |
135 |
$141.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
367 |
340 |
$102.13 |
| 87807 |
|
86 |
83 |
$86.52 |
| 90471 |
|
60 |
54 |
$52.92 |
| 83540 |
|
12 |
12 |
$50.30 |
| 83550 |
|
12 |
12 |
$50.30 |
| 80143 |
|
24 |
24 |
$41.75 |
| 82962 |
|
107 |
79 |
$37.71 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
106 |
85 |
$28.24 |
| 80179 |
|
12 |
12 |
$26.84 |
| 81015 |
|
439 |
420 |
$12.63 |
| 85652 |
|
39 |
38 |
$11.78 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
12 |
$6.77 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
135 |
116 |
$6.16 |
| 82150 |
|
13 |
12 |
$6.03 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
19 |
13 |
$5.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
41 |
31 |
$5.00 |
| J2704 |
Injection, propofol, 10 mg |
106 |
99 |
$1.61 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
32 |
25 |
$1.60 |
| 87040 |
|
27 |
25 |
$1.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
14 |
$1.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
76 |
68 |
$0.35 |
| 99080 |
|
898 |
147 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
46 |
45 |
$0.00 |